Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D V Jackson

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical trial of folinic acid to reduce vincristine neurotoxicityD V Jackson, R A McMahan, E K Pope, et al.
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Dose-related pharmacologic effects of high dose ara-C and its use in combination with asparaginase for the treatment of patients with acute non-lymphocytic leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Journal of Neuro-Oncology|January 1, 1984
Improved tolerance of vincristine by glutamic acid. A preliminary reportD V Jackson, E K Pope, L D Case, et al.
Journal of Neuro-Oncology|January 1, 1986
Clinical trial of pyridoxine to reduce vincristine neurotoxicityD V Jackson, E K Pope, R A McMahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association studyH B Muss, L D Case, J N Atkins, et al.
Cancer|December 1, 1982
Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology AssociationH B Muss, F Richards, D V Jackson, et al.
Cancer|June 15, 1981
Combination chemotherapy with and without the methanol-extracted residue of bacillus Calmette-Guerin (MER) in extensive non-small-cell lung cancer: a prospective randomized study for the Piedmont Oncology AssociationF Richards, V Howard, A Shore, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Continuous intravenous infusion of vinca alkaloid using a subcutaneously implanted pump in a canine modelD V Jackson, M L Barringer, D L Rosenbaum, et al.
Cancer|July 1, 1982
Combination chemotherapy-radiotherapy with and without the methanol-extraction residue of Bacillus Calmette-Guerin (MER) in small cell carcinoma of the lung: a prospective randomized trial of the Piedmont Oncology AssociationD V Jackson, B R Paschal, C Ferree, et al.
Cancer|December 15, 1981
Intravenous vincristine infusion: phase I trialD V Jackson, V S Sethi, C L Spurr, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical trial of folinic acid to reduce vincristine neurotoxicityD V Jackson, R A McMahan, E K Pope, et al.
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Dose-related pharmacologic effects of high dose ara-C and its use in combination with asparaginase for the treatment of patients with acute non-lymphocytic leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Journal of Neuro-Oncology|January 1, 1984
Improved tolerance of vincristine by glutamic acid. A preliminary reportD V Jackson, E K Pope, L D Case, et al.
Journal of Neuro-Oncology|January 1, 1986
Clinical trial of pyridoxine to reduce vincristine neurotoxicityD V Jackson, E K Pope, R A McMahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association studyH B Muss, L D Case, J N Atkins, et al.
Cancer|December 1, 1982
Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology AssociationH B Muss, F Richards, D V Jackson, et al.
Cancer|June 15, 1981
Combination chemotherapy with and without the methanol-extracted residue of bacillus Calmette-Guerin (MER) in extensive non-small-cell lung cancer: a prospective randomized study for the Piedmont Oncology AssociationF Richards, V Howard, A Shore, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Continuous intravenous infusion of vinca alkaloid using a subcutaneously implanted pump in a canine modelD V Jackson, M L Barringer, D L Rosenbaum, et al.
Cancer|July 1, 1982
Combination chemotherapy-radiotherapy with and without the methanol-extraction residue of Bacillus Calmette-Guerin (MER) in small cell carcinoma of the lung: a prospective randomized trial of the Piedmont Oncology AssociationD V Jackson, B R Paschal, C Ferree, et al.
Cancer|December 15, 1981
Intravenous vincristine infusion: phase I trialD V Jackson, V S Sethi, C L Spurr, et al.
Pageof 10